193 related articles for article (PubMed ID: 34142629)
1. Factor XII(a) inhibitors: a review of the patent literature.
Kalinin DV
Expert Opin Ther Pat; 2021 Dec; 31(12):1155-1176. PubMed ID: 34142629
[No Abstract] [Full Text] [Related]
2. Factor XII/XIIa inhibitors: Their discovery, development, and potential indications.
Davoine C; Bouckaert C; Fillet M; Pochet L
Eur J Med Chem; 2020 Dec; 208():112753. PubMed ID: 32883641
[TBL] [Abstract][Full Text] [Related]
3. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases.
Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692
[TBL] [Abstract][Full Text] [Related]
4. Factor XII: a drug target for safe interference with thrombosis and inflammation.
Kenne E; Renné T
Drug Discov Today; 2014 Sep; 19(9):1459-64. PubMed ID: 24993156
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer.
Woodruff RS; Xu Y; Layzer J; Wu W; Ogletree ML; Sullenger BA
J Thromb Haemost; 2013 Jul; 11(7):1364-73. PubMed ID: 23692437
[TBL] [Abstract][Full Text] [Related]
6. Factor XII: a novel target for safe prevention of thrombosis and inflammation.
Kenne E; Nickel KF; Long AT; Fuchs TA; Stavrou EX; Stahl FR; Renné T
J Intern Med; 2015 Dec; 278(6):571-85. PubMed ID: 26373901
[TBL] [Abstract][Full Text] [Related]
7. Factor XII truncation accelerates activation in solution.
de Maat S; Clark CC; Boertien M; Parr N; Sanrattana W; Hofman ZLM; Maas C
J Thromb Haemost; 2019 Jan; 17(1):183-194. PubMed ID: 30394658
[TBL] [Abstract][Full Text] [Related]
8. Factor XII inhibition reduces thrombus formation in a primate thrombosis model.
Matafonov A; Leung PY; Gailani AE; Grach SL; Puy C; Cheng Q; Sun MF; McCarty OJ; Tucker EI; Kataoka H; Renné T; Morrissey JH; Gruber A; Gailani D
Blood; 2014 Mar; 123(11):1739-46. PubMed ID: 24408325
[TBL] [Abstract][Full Text] [Related]
9. A nanobody-based method for tracking factor XII activation in plasma.
de Maat S; van Dooremalen S; de Groot PG; Maas C
Thromb Haemost; 2013 Sep; 110(3):458-68. PubMed ID: 23349032
[TBL] [Abstract][Full Text] [Related]
10. Coagulation factor XII in thrombosis and inflammation.
Maas C; Renné T
Blood; 2018 Apr; 131(17):1903-1909. PubMed ID: 29483100
[TBL] [Abstract][Full Text] [Related]
11. An update on factor XII-driven vascular inflammation.
Mailer RK; Rangaswamy C; Konrath S; Emsley J; Renné T
Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119166. PubMed ID: 34699874
[TBL] [Abstract][Full Text] [Related]
12. Factor XII Contact Activation.
Naudin C; Burillo E; Blankenberg S; Butler L; Renné T
Semin Thromb Hemost; 2017 Nov; 43(8):814-826. PubMed ID: 28346966
[TBL] [Abstract][Full Text] [Related]
13. In vivo roles of factor XII.
Renné T; Schmaier AH; Nickel KF; Blombäck M; Maas C
Blood; 2012 Nov; 120(22):4296-303. PubMed ID: 22993391
[TBL] [Abstract][Full Text] [Related]
14. Contact activation-induced complex formation between complement factor H and coagulation factor XIIa.
Thangaraj SS; Christiansen SH; Graversen JH; Sidelmann JJ; Hansen SWK; Bygum A; Gram JB; Palarasah Y
J Thromb Haemost; 2020 Apr; 18(4):876-884. PubMed ID: 31984663
[TBL] [Abstract][Full Text] [Related]
15. The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities.
Worm M; Köhler EC; Panda R; Long A; Butler LM; Stavrou EX; Nickel KF; Fuchs TA; Renné T
Ann Transl Med; 2015 Oct; 3(17):247. PubMed ID: 26605293
[TBL] [Abstract][Full Text] [Related]
16. Differential binding of factor XII and activated factor XII to soluble and immobilized fibronectin--localization of the Hep-1/Fib-1 binding site for activated factor XII.
Schousboe I; Nystrøm BT; Hansen GH
FEBS J; 2008 Oct; 275(20):5161-72. PubMed ID: 18793325
[TBL] [Abstract][Full Text] [Related]
17. Contact system revisited: an interface between inflammation, coagulation, and innate immunity.
Long AT; Kenne E; Jung R; Fuchs TA; Renné T
J Thromb Haemost; 2016 Mar; 14(3):427-37. PubMed ID: 26707513
[TBL] [Abstract][Full Text] [Related]
18. CpaA Is a Glycan-Specific Adamalysin-like Protease Secreted by Acinetobacter baumannii That Inactivates Coagulation Factor XII.
Waack U; Warnock M; Yee A; Huttinger Z; Smith S; Kumar A; Deroux A; Ginsburg D; Mobley HLT; Lawrence DA; Sandkvist M
mBio; 2018 Dec; 9(6):. PubMed ID: 30563903
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
[TBL] [Abstract][Full Text] [Related]
20. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis.
Kleinschnitz C; Stoll G; Bendszus M; Schuh K; Pauer HU; Burfeind P; Renné C; Gailani D; Nieswandt B; Renné T
J Exp Med; 2006 Mar; 203(3):513-8. PubMed ID: 16533887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
